NO960268L - Nye dialkoksypyridinylbenzimidazolderivater - Google Patents

Nye dialkoksypyridinylbenzimidazolderivater

Info

Publication number
NO960268L
NO960268L NO960268A NO960268A NO960268L NO 960268 L NO960268 L NO 960268L NO 960268 A NO960268 A NO 960268A NO 960268 A NO960268 A NO 960268A NO 960268 L NO960268 L NO 960268L
Authority
NO
Norway
Prior art keywords
compounds
methyl
new
dialkoxypyridinylbenzimidazole
derivatives
Prior art date
Application number
NO960268A
Other languages
English (en)
Norwegian (no)
Other versions
NO960268D0 (no
Inventor
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Per Oskar Sverker Von Unge
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO960268D0 publication Critical patent/NO960268D0/no
Publication of NO960268L publication Critical patent/NO960268L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO960268A 1994-05-27 1996-01-23 Nye dialkoksypyridinylbenzimidazolderivater NO960268L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25617194A 1994-05-27 1994-05-27
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (fr) 1994-05-27 1995-05-11 Nouveaux derives de dialcoxy-pyridinyl-benzimidazole

Publications (2)

Publication Number Publication Date
NO960268D0 NO960268D0 (no) 1996-01-23
NO960268L true NO960268L (no) 1996-01-23

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960268A NO960268L (no) 1994-05-27 1996-01-23 Nye dialkoksypyridinylbenzimidazolderivater

Country Status (18)

Country Link
EP (1) EP0712401A1 (fr)
JP (1) JPH09504557A (fr)
CN (1) CN1128997A (fr)
AU (1) AU2633095A (fr)
BR (1) BR9506235A (fr)
CA (1) CA2166988A1 (fr)
CZ (1) CZ24396A3 (fr)
EE (1) EE9600011A (fr)
FI (1) FI960367A7 (fr)
HU (1) HU9600005D0 (fr)
IL (1) IL113604A0 (fr)
IS (1) IS4321A (fr)
MA (1) MA23563A1 (fr)
NO (1) NO960268L (fr)
PL (1) PL312692A1 (fr)
TN (1) TNSN95062A1 (fr)
WO (1) WO1995032959A1 (fr)
ZA (1) ZA954125B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
ES2222754T3 (es) 1998-11-18 2005-02-01 Astrazeneca Ab Procedimiento quimico mejorado, y formulacion farmaceutica.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2007317561A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CN101980700A (zh) 2008-02-20 2011-02-23 密苏里大学董事会 包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
CA2764963C (fr) 2009-06-25 2016-11-01 Astrazeneca Ab Procede pour le traitement d'un patient a risque de developer un ulcere associe a nsaid
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2140391T3 (es) * 1990-06-20 2000-03-01 Astra Ab Derivados de dialcoxi-piridinil-bencimidazol, procedimiento para su preparacion y su uso farmaceutico.
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung

Also Published As

Publication number Publication date
NO960268D0 (no) 1996-01-23
IS4321A (is) 1996-01-17
FI960367L (fi) 1996-01-26
EP0712401A1 (fr) 1996-05-22
HU9600005D0 (en) 1996-03-28
CZ24396A3 (en) 1996-06-12
JPH09504557A (ja) 1997-05-06
FI960367A0 (fi) 1996-01-26
ZA954125B (en) 1995-11-27
BR9506235A (pt) 1997-08-12
FI960367A7 (fi) 1996-01-26
TNSN95062A1 (fr) 1996-02-06
CA2166988A1 (fr) 1995-12-07
EE9600011A (et) 1996-04-15
IL113604A0 (en) 1995-08-31
WO1995032959A1 (fr) 1995-12-07
CN1128997A (zh) 1996-08-14
PL312692A1 (en) 1996-05-13
AU2633095A (en) 1995-12-21
MA23563A1 (fr) 1995-12-31

Similar Documents

Publication Publication Date Title
RU95105587A (ru) Оптически чистые соединения пиридинилметил сульфинил-1н-бензимидазола, их соли, способы получения, фармкомпозиция, способ лечения
NO160204C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkalisalter av 5-metoksy-2(((4-metoksy-3,5-dimetyl-2-pyridinyl)-metyl)-sulfinyl)-1h-benzimidazol.
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
ATE698T1 (de) Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
NO171915C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azabicyklo(4.2.0)okt-2-en-derivater
NO178338C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse samt mellomprodukt
DE3767114D1 (de) Stabilisierte arzneimittel.
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
TNSN95062A1 (fr) Nouveaux derives dialkoxy-pyridinyle-benzimidazole
NO960267L (no) Nye substituerte benzimidazoler
AU545254B2 (en) Benzo (4,5) pyrano (2,3c) pyrroles, processes for their preparation and pharmaceutical preparations containing same
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
JO1871B1 (en) Innovative substituted benzimidazole compounds
JO1870B1 (en) CO2 derivatives - pyridinyl benzimidazole innovative
EP0192393A3 (fr) Dérivés d'alkyl-furanone
FI893570A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
DE69000806D1 (de) Indol-derivate.
PT92877A (pt) Processo de preparacao de derivados da benzonaftiridina-(1,8)
AU3998489A (en) New benzopyrrolidinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
HUT42093A (en) Process for preparing 2-/2-thienyl/-imidazo/4,5-e/pyridine derivatives ang pharmaceutically acceptable acid addition salts thereof
DK210387A (da) Heterocykliske forbindelser og fremgangsmaade til deres fremstilling samt farmaceutiske midler indeholdende disse
JO1660B1 (en) Benzimidazole compounds are a therapeutically effective substitute for chlorine and processes for preparing and using them